Dr. J. Joseph Kim, CEO at Inovio Pharmaceuticals, discusses vaccine development for COVID-19. Kim points out that there's been "a lot of incremental successes" in phase one trials. He also talks about the importance of ensuring safety and efficacy.
Hosts: Carol Massar and Jason Kelly. Producer: Doni Holloway.

Bloomberg Businessweek Weekend: July 31st 2026
38:26

Warsh Considers Fewer Fed Meetings; Anthropic AI Models Hack Three Organizations
40:03

Aon Keeps Margin Edge as Industry Tailwinds Fade
11:01